Brii Biosciences Limited (2137.HK) HKSE

2.00

-0.03(-1.48%)

Updated at August 22 04:08PM

Currency In HKD

Valuation

Market Cap672.13M
Enterprise Value-303.21M
P/E Ratio-2.64
PEG Ratio0.03
Price/Sales Ratio24.72
Price/Book Ratio0.5
Enterprise/Revenue6.75
Enterprise/EBITDA-0.93

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterDecember 31, 2024

Profitability

Profit Margin-9.36
Operating Margin-7.36

Management Effectiveness

Return On Assets-0.19
Return On Equity-0.18

Income Statement

Revenue54.29M
Revenue/Share0.07
Gross Profit54.29M
EBITDA-392.52M
Net Income-508.16M
Diluted EPS-0.7

Balance Sheet

Total Cash2.33B
Total Cash/Share3.19
Total Debt28.02M
Total Debt/Equity0.01
Current Ratio31.18
Book Value Per Share3.57

Price History

52-Week Change108.33
52-Week High3.09
52-Week Low0.8
Moving Average 50 Days1.92
Moving Average 200 Days1.63

Statistics

Average Volume6.21M
Shares Outstanding732.1M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A